Kim et al. (2015) showed that serum cystatin C predicted the incidence of contrast-induced nephropathy in PAD patients undergoing endovascular intervention, with an area under the receiver operating characteristic curve (AUROC) of 0.76 [37]. This evidence concerns the gene CST3 and peripheral arterial disease.